MeSH term | MeSH ID | Detail |
---|---|---|
Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Hyperlipidemias | D006949 | 73 associated lipids |
1-octadecanoyl-sn-glycero-3-phosphocholine is a lipid of Glycerophospholipids (GP) class. 1-octadecanoyl-sn-glycero-3-phosphocholine is associated with abnormalities such as Septicemia. The involved functions are known as Phosphorylation, MAP kinase activity, Phagocytosis, protein serine/threonine kinase activity and Uptake. The associated genes with 1-octadecanoyl-sn-glycero-3-phosphocholine are FPR1 gene and OLR1 gene. The related lipids are Lysophosphatidylcholines.
To understand associated biological information of 1-octadecanoyl-sn-glycero-3-phosphocholine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
1-octadecanoyl-sn-glycero-3-phosphocholine is suspected in Septicemia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with 1-octadecanoyl-sn-glycero-3-phosphocholine
MeSH term | MeSH ID | Detail |
---|---|---|
Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Hyperlipidemias | D006949 | 73 associated lipids |
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid: | ||||
King MT et al. | Failure to detect mutagenic effects of anti-tumor alkyl-lysophospholipids. | 1981 | Cancer Lett. | pmid:6790162 |
Berdel WE et al. | Early tumor and leukemia response to alkyllysophospholipids in a phase I study. | 1982 | Cancer | pmid:7127246 |
Wu W et al. | Lamellar--micellar transition of 1-stearoyllysophosphatidylcholine assemblies in excess water. | 1982 | Biochemistry | pmid:7150539 |
Berdel WE et al. | Alkyl-lysophospholipids lack influence on the occurrence of radiation-induced lymphomas and AKR-leukemia. | 1983 | Cancer Lett. | pmid:6686802 |
Hui SW and Huang CH | X-ray diffraction evidence for fully interdigitated bilayers of 1-stearoyllysophosphatidylcholine. | 1986 | Biochemistry | pmid:3964679 |
Zakim D et al. | Phospholipids and UDP-glucuronosyltransferase. Structure/function relationships. | 1988 | J. Biol. Chem. | pmid:3128536 |
Vesterqvist O et al. | Quantitation of lysophosphatidylcholine molecular species in rat cardiac tissue. | 1992 | Anal. Biochem. | pmid:1514697 |
Günther-Ausborn S and Stegmann T | How lysophosphatidylcholine inhibits cell-cell fusion mediated by the envelope glycoprotein of human immunodeficiency virus. | 1997 | Virology | pmid:9281499 |
Shi AH et al. | Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes. | 1999 | Horm. Metab. Res. | pmid:10333086 |